Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sulfur hexafluoride - Bracco

Drug Profile

Sulfur hexafluoride - Bracco

Alternative Names: BRI; E-7210; Lumason; SonoVue; sulfur hexafluoride lipid-type A microspheres; Sulphur hexafluoride

Latest Information Update: 03 Sep 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bracco
  • Developer Bracco; Eisai Co Ltd
  • Class Contrast media; Fluorides; Inorganic sulfur compounds; Small molecules
  • Mechanism of Action Ultrasonography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Cerebrovascular disorders
  • Registered Cardiovascular disorders; Liver disorders; Vesicoureteral reflux
  • Phase III Congenital heart defects; Coronary artery disease

Most Recent Events

  • 17 Aug 2018 Bracco Diagnostics terminates phase III trial due to difficulties enrolling patients in Congenital heart disorders (In children, In adolescents, Diagnosis) in USA (IV) (NCT02282163)
  • 24 Jun 2018 Biomarkers information updated
  • 25 Feb 2018 Bracco completes a phase III trial in Coronary artery disease (Diagnosis) in USA, United Kingdom, Belgium (IV) (EudraCT2015-001962-25)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top